药用甘油市场规模、份额及成长分析（按类型、原料、应用及地区划分）－2025-2032年产业预测

预计到 2024 年，全球药用甘油市场规模将达到 3,850 万美元，到 2025 年将成长至 4,108 万美元，到 2033 年将成长至 6,901 万美元，预测期（2026-2033 年）的复合年增长率为 6.7%。

全球药用甘油市场正经历显着成长，这主要得益于其安全性和多功能性，使其在胶囊、糖浆和外用製剂等药物製剂中的应用范围不断扩大。新兴市场对止咳糖浆、创伤护理软膏和甘油胶囊的需求不断增长，推动了甘油的消费。製药业的进步，尤其是在亚太和拉丁美洲地区，以及高纯度甘油生产製程的改进，也为此成长提供了支持。消费者对植物来源甘油的日益青睐，进一步推动了向永续生物基材料的转变。然而，原材料供应波动、与监管合规相关的生产成本以及棕榈油和大豆油市场的波动等挑战，可能会影响甘油的价格和供应。

全球药用甘油市场驱动因素

全球药用甘油市场的主要驱动因素之一是药物製剂中对天然和有机成分日益增长的需求。随着製药业日益关注永续性以及消费者对环保产品的偏好，源自可再生资源的甘油因其在药物、添加剂和防冻剂配方中的广泛应用而备受关注。此外，甘油的多功能特性，例如作为高效保湿剂、溶剂和甜味剂，使其成为多种药物产品开发中不可或缺的成分，进一步推动了其广泛应用和市场成长。

限制全球药用甘油市场的因素

全球药用甘油市场面临的主要限制因素之一是严格的法规环境，该环境规范着药品生产和使用中的甘油。遵守各项国际品质标准和法规对生产商构成重大挑战，可能导致成本增加和研发週期延长。此外，污染风险以及确保产品纯度一致性的要求也限制了产能。这些监管障碍可能阻碍中小企业进入市场，导致整体竞争和创新能力下降，从而阻碍市场成长和扩张。

全球药用甘油市场趋势

全球药用甘油市场正经历着向植物来源甘油的显着转变，这主要得益于消费者对永续和纯素产品日益增长的需求。这一趋势反映出企业普遍致力于符合道德规范的采购和洁净标示理念，并优先考虑配方中的透明度和环境责任。天然辅料的应用正在迅速发展，尤其是在欧洲和北美等关键地区，而鼓励使用永续成分的监管标准的不断改进也进一步加速了这一趋势。随着人们对植物来源替代品益处的认识不断提高，预计市场将继续扩张，从而推动创新应用和配方的开发。

目录

介绍

• 调查目标
• 市场定义和范围

调查方法

• 调查过程
• 二手资料和一手资料方法
• 市场规模估算方法

执行摘要

• 全球市场展望
• 主要市场亮点
• 细分市场概览
• 竞赛概况

市场动态与展望

• 总体经济指标
• 驱动因素和机会
• 限制与挑战
• 供给面趋势
• 需求面趋势
• 波特分析及其影响

关键市场考察

• 关键成功因素
• 影响市场的因素
• 关键投资机会
• 生态系测绘
• 市场吸引力指数（2025）
• PESTEL 分析
• 价值链分析
• 定价分析
• 案例研究
• 监管环境
• 技术评估

全球药用甘油市场规模（按类型和复合年增长率划分）（2026-2033 年）

• 纯度99.7%
• 纯度99.7%或更高

全球药用甘油市场规模（按来源和复合年增长率划分）（2026-2033 年）

• 动物源性
• 植物来源

全球药用甘油市场规模（按应用领域及复合年增长率划分）（2026-2033 年）

• 口服
• 外用

全球药用甘油市场规模及复合年增长率（2026-2033）

• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲地区
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 亚太其他地区
• 拉丁美洲
  • 墨西哥
  • 巴西
  • 其他拉丁美洲地区
• 中东和非洲
  • 海湾合作委员会国家
  • 南非
  • 其他中东和非洲地区

竞争资讯

• 前五大公司对比
• 主要企业的市场定位（2025 年）
• 主要市场参与者所采取的策略
• 近期市场趋势
• 公司市占率分析（2025 年）
• 主要企业公司简介
  • 公司详情
  • 产品系列分析
  • 依业务板块进行公司股票分析
  • 2023-2025年营收年比比较

主要企业简介

• IOI Oleo GmbH（Germany）
• Archer Daniels Midland Company（ADM）（United States）
• KLK Oleo（Malaysia）
• Oleon NV（Belgium）
• Dow, Inc.（United States）
• Cargill, Incorporated（United States）
• Emery Oleochemicals（Malaysia）
• P&G Chemicals（United States）
• Wilmar International Limited（Singapore）
• The Chemical Company（TCC）（United States）
• Godrej Industries Limited（India）
• Twin Rivers Technologies, Inc.（United States）
• VVF LLC（India）
• Avril Group（France）
• GLACONCHEMIE GmbH（Germany）
• Croda International Plc（United Kingdom）
• Rajaram Solvents Pvt. Ltd.（India）
• 3F Chimica SpA（Italy）
• Solvay SA（Belgium）
• Peter Greven GmbH & Co. KG（Germany）

结论与建议

Global Pharmaceutical Glycerine Market size was valued at USD 38.5 million in 2024 and is poised to grow from USD 41.08 million in 2025 to USD 69.01 million by 2033, growing at a CAGR of 6.7% during the forecast period (2026-2033).

The global pharmaceutical glycerine market is witnessing significant growth driven by its expanding applications in drug formulations, including capsules, syrups, and topical products, owing to its safety and versatility. The rising demand for cough syrups, wound care ointments, and glycerine-based capsules in emerging markets is fueling consumption. This growth is also bolstered by advancements in the pharmaceutical sector, particularly in the Asia-Pacific and Latin America regions, alongside improvements in manufacturing processes that yield higher purity glycerine. The increasing preference for plant-derived glycerine is further supporting the shift towards sustainable bio-based materials. However, challenges such as raw material supply fluctuations, production costs due to regulatory compliance, and disruptions in the palm oil and soybean oil markets may impact pricing and availability.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Pharmaceutical Glycerine market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Pharmaceutical Glycerine Market Segments Analysis

Global Pharmaceutical Glycerine Market is segmented by Type, Source, Application and region. Based on Type, the market is segmented into 99.7% Purity and Above 99.7% Purity. Based on Source, the market is segmented into Animal and Plant. Based on Application, the market is segmented into Oral Use and External use. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Pharmaceutical Glycerine Market

One of the key market drivers for the global pharmaceutical glycerine market is the rising demand for natural and organic ingredients in drug formulations. As the pharmaceutical industry increasingly focuses on sustainability and consumer preferences for eco-friendly products, glycerine, derived from renewable sources, is gaining traction for its diverse applications in medicines, excipients, and antifreeze formulations. Additionally, glycerine's multifunctional properties, such as being an effective humectant, solvent, and sweetening agent, make it an essential component in the development of various pharmaceutical products, further boosting its utilization and driving market growth.

Restraints in the Global Pharmaceutical Glycerine Market

One key market restraint for the Global Pharmaceutical Glycerine Market is the stringent regulatory environment governing the production and use of glycerine in pharmaceuticals. Compliance with varied international quality standards and regulations can pose significant challenges for manufacturers, leading to increased costs and longer development timelines. Additionally, the potential for contamination and the need for consistent product purity can limit production capabilities. These regulatory hurdles can deter small and medium-sized enterprises from entering the market, thus reducing overall competition and innovation, ultimately hindering market growth and expansion.

Market Trends of the Global Pharmaceutical Glycerine Market

The global pharmaceutical glycerine market is witnessing a significant shift towards plant-based glycerine, fueled by increasing consumer demand for sustainable and vegan-friendly products. This trend reflects a broader commitment to ethical sourcing and clean-label initiatives, as companies prioritize transparency and environmental responsibility in their formulations. The rise of regulatory standards favoring sustainable ingredients further amplifies this movement, particularly in key regions like Europe and North America, where the adoption of natural excipients is rapidly gaining momentum. As awareness of the benefits of plant-derived alternatives continues to grow, the market is expected to expand, leading to innovative applications and formulations.

Table of Contents

Introduction

• Objectives of the Study
• Market Definition & Scope

Research Methodology

• Research Process
• Secondary & Primary Data Methods
• Market Size Estimation Methods

Executive Summary

• Global Market Outlook
• Key Market Highlights
• Segmental Overview
• Competition Overview

Market Dynamics & Outlook

• Macro-Economic Indicators
• Drivers & Opportunities
• Restraints & Challenges
• Supply Side Trends
• Demand Side Trends
• Porters Analysis & Impact
  • Competitive Rivalry
  • Threat of Substitute
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Key Success Factors
• Market Impacting Factors
• Top Investment Pockets
• Ecosystem Mapping
• Market Attractiveness Index, 2025
• PESTEL Analysis
• Value Chain Analysis
• Pricing Analysis
• Case Studies
• Regulatory Landscape
• Technology Assessment

Global Pharmaceutical Glycerine Market Size by Type & CAGR (2026-2033)

• Market Overview
• 99.7% Purity
• Above 99.7% Purity

Global Pharmaceutical Glycerine Market Size by Source & CAGR (2026-2033)

• Market Overview
• Animal
• Plant

Global Pharmaceutical Glycerine Market Size by Application & CAGR (2026-2033)

• Market Overview
• Oral Use
• External use

Global Pharmaceutical Glycerine Market Size & CAGR (2026-2033)

• North America (Type, Source, Application)
  • US
  • Canada
• Europe (Type, Source, Application)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Type, Source, Application)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Type, Source, Application)
  • Mexico
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Type, Source, Application)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• IOI Oleo GmbH (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Archer Daniels Midland Company (ADM) (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• KLK Oleo (Malaysia)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Oleon NV (Belgium)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Dow, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cargill, Incorporated (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Emery Oleochemicals (Malaysia)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• P&G Chemicals (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Wilmar International Limited (Singapore)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• The Chemical Company (TCC) (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Godrej Industries Limited (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Twin Rivers Technologies, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• VVF LLC (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Avril Group (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GLACONCHEMIE GmbH (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Croda International Plc (United Kingdom)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Rajaram Solvents Pvt. Ltd. (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• 3F Chimica SpA (Italy)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Solvay SA (Belgium)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Peter Greven GmbH & Co. KG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations